| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.599 | 0.036 | 0.599 | Caspase 9 stimulant | 0.479 0.069 CID_53790925 | ||
| 0.563 | 0.013 | 0.563 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.427 0.078 CID_53790925 | ||
| 0.554 | 0.014 | 0.554 | GABA C receptor rho-3 antagonist | 0.349 0.086 CID_53790925 | ||
| 0.542 | 0.021 | 0.542 | 5 Hydroxytryptamine release inhibitor | 0.387 0.087 CID_53790925 | ||
| 0.507 | 0.032 | 0.507 | Aldehyde oxidase inhibitor | 0.33 0.059 CID_53790925 | ||
| 0.474 | 0.005 | 0.474 | p38 MAP kinase inhibitor | |||
| 0.491 | 0.031 | 0.491 | Calcium channel L-type activator | 0.339 0.126 CID_53790925 | ||
| 0.482 | 0.035 | 0.482 | Histamine release inhibitor | 0.359 0.096 CID_53790925 | ||
| 0.415 | 0.004 | 0.415 | T cell inhibitor | 0.164 0.009 CID_53790925 | ||
| 0.444 | 0.037 | 0.444 | 5 Hydroxytryptamine release stimulant | 0.237 0.096 CID_53790925 | ||
| 0.43 | 0.032 | 0.43 | Aryl hydrocarbon receptor agonist | |||
| 0.404 | 0.023 | 0.404 | Calcium channel activator | 0.33 0.064 CID_53790925 | ||
| 0.395 | 0.015 | 0.395 | 5 Hydroxytryptamine uptake stimulant | 0.298 0.046 CID_53790925 | ||
| 0.397 | 0.021 | 0.397 | Peroxidase inhibitor | 0.195 0.06 CID_53790925 | ||
| 0.364 | 0.013 | 0.364 | Tyrosine 3 hydroxylase inhibitor | 0.266 0.054 CID_53790925 | ||
| 0.367 | 0.033 | 0.367 | Superoxide dismutase inhibitor | 0.232 0.088 CID_53790925 | ||
| 0.335 | 0.003 | 0.335 | CYP2A6 inhibitor | 0.121 0.026 CID_53790925 | ||
| 0.34 | 0.01 | 0.34 | Neurotrophic factor enhancer | 0.274 0.027 CID_53790925 | ||
| 0.372 | 0.044 | 0.372 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.326 | 0.005 | 0.326 | Ferrochelatase inhibitor | 0.169 0.031 CID_53790925 | ||
| 0.343 | 0.025 | 0.343 | RNA-directed DNA polymerase inhibitor | 0.29 0.034 CID_53790925 | ||
| 0.329 | 0.013 | 0.383 | Alpha-N-acetylglucosaminidase inhibitor | 0.383 0.01 CID_53790925 | CID_53790925 | |
| 0.314 | 0.02 | 0.314 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.288 0.028 CID_53790925 | ||
| 0.298 | 0.012 | 0.298 | 3C-like protease (Human coronavirus) inhibitor | 0.149 0.102 CID_53790925 | ||
| 0.311 | 0.026 | 0.311 | Gastrin inhibitor | 0.311 0.026 CID_53790925 | ||
| 0.286 | 0.006 | 0.286 | 5 Hydroxytryptamine 3E antagonist | 0.171 0.131 CID_53790925 | ||
| 0.34 | 0.069 | 0.34 | Cholesterol antagonist | 0.298 0.092 CID_53790925 | ||
| 0.28 | 0.011 | 0.28 | Cystathionine beta-synthase inhibitor | 0.219 0.02 CID_53790925 | ||
| 0.316 | 0.05 | 0.316 | Insulysin inhibitor | |||
| 0.276 | 0.014 | 0.276 | Aldehyde dehydrogenase inhibitor | 0.142 0.053 CID_53790925 | ||
| 0.266 | 0.005 | 0.266 | CF transmembrane conductance regulator agonist | 0.213 0.015 CID_53790925 | ||
| 0.28 | 0.021 | 0.28 | NOS3 expression enhancer | 0.158 0.065 CID_53790925 | ||
| 0.293 | 0.035 | 0.293 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.295 | 0.041 | 0.295 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.257 | 0.005 | 0.257 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.139 0.095 CID_53790925 | ||
| 0.249 | 0.008 | 0.249 | Alcohol dehydrogenase inhibitor | 0.115 0.039 CID_53790925 | ||
| 0.288 | 0.048 | 0.366 | DNA synthesis inhibitor | 0.366 0.027 CID_53790925 | CID_53790925 | |
| 0.245 | 0.006 | 0.245 | Photosensitizer | 0.169 0.022 CID_53790925 | ||
| 0.263 | 0.025 | 0.263 | Nitric-oxide synthase stimulant | 0.242 0.038 CID_53790925 | ||
| 0.333 | 0.096 | 0.482 | Immunosuppressant | 0.482 0.038 CID_53790925 | CID_53790925 | |
| 0.242 | 0.005 | 0.242 | Papain-like protease (SARS coronavirus) inhibitor | 0.162 0.025 CID_53790925 | ||
| 0.322 | 0.086 | 0.322 | Vasodilator, peripheral | 0.23 0.144 CID_53790925 | ||
| 0.339 | 0.106 | 0.339 | 15-Lipoxygenase inhibitor | 0.247 0.167 CID_53790925 | ||
| 0.242 | 0.013 | 0.242 | Carbonic anhydrase XV inhibitor | 0.124 0.044 CID_53790925 | ||
| 0.283 | 0.057 | 0.283 | Interleukin agonist | 0.233 0.092 CID_53790925 | ||
| 0.267 | 0.043 | 0.267 | Anesthetic general | 0.266 0.043 CID_53790925 | ||
| 0.26 | 0.039 | 0.26 | Non-steroidal antiinflammatory agent | |||
| 0.243 | 0.025 | 0.243 | Succinate dehydrogenase inhibitor | 0.176 0.072 CID_53790925 | ||
| 0.299 | 0.08 | 0.299 | 12-Lipoxygenase inhibitor | |||
| 0.221 | 0.003 | 0.221 | Purinergic P2Y14 antagonist | 0.027 0.025 CID_53790925 | ||
| 0.307 | 0.09 | 0.404 | Transcription factor NF kappa B inhibitor | 0.404 0.063 CID_53790925 | CID_53790925 | |
| 0.234 | 0.018 | 0.273 | ATPase inhibitor | 0.273 0.009 CID_53790925 | CID_53790925 | |
| 0.269 | 0.055 | 0.269 | Cyclic AMP phosphodiesterase inhibitor | 0.188 0.103 CID_53790925 | ||
| 0.243 | 0.029 | 0.243 | Histone acetyltransferase inhibitor | |||
| 0.22 | 0.006 | 0.22 | Sphingosine 1-phosphate receptor 4 antagonist | 0.172 0.018 CID_53790925 | ||
| 0.285 | 0.073 | 0.317 | Hypoxia-inducible factor 1 alpha inhibitor | 0.317 0.058 CID_53790925 | CID_53790925 | |
| 0.224 | 0.013 | 0.224 | Nav1.6 sodium channel blocker | |||
| 0.276 | 0.067 | 0.291 | DNA damaging | 0.291 0.061 CID_53790925 | CID_53790925 | |
| 0.307 | 0.099 | 0.307 | Prostaglandin dehydrogenase inhibitor | |||
| 0.225 | 0.018 | 0.225 | GABA C receptor rho-2 antagonist | 0.127 0.112 CID_53790925 | ||
| 0.256 | 0.049 | 0.256 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.245 | 0.041 | 0.245 | LIM domain kinase 1 inhibitor | |||
| 0.223 | 0.02 | 0.223 | Mannose-6-phosphate isomerase inhibitor | 0.173 0.047 CID_53790925 | ||
| 0.235 | 0.032 | 0.235 | Heat shock protein 90 alpha antagonist | 0.164 0.074 CID_53790925 | ||
| 0.229 | 0.028 | 0.229 | Cytokine production inhibitor | |||
| 0.21 | 0.011 | 0.21 | Porphobilinogen synthase inhibitor | 0.095 0.038 CID_53790925 | ||
| 0.225 | 0.028 | 0.225 | Heat shock protein 90 antagonist | 0.222 0.029 CID_53790925 | ||
| 0.215 | 0.018 | 0.215 | GABA C receptor agonist | 0.123 0.047 CID_53790925 | ||
| 0.206 | 0.01 | 0.206 | HIV-1 integrase (Overall Integration) inhibitor | 0.11 0.046 CID_53790925 | ||
| 0.241 | 0.058 | 0.241 | MAP kinase kinase 2 inhibitor | |||
| 0.207 | 0.027 | 0.207 | Catenin beta inhibitor | |||
| 0.202 | 0.023 | 0.202 | Toll-Like receptor 2 antagonist | 0.147 0.055 CID_53790925 | ||
| 0.242 | 0.063 | 0.242 | Pyruvate kinase inhibitor | |||
| 0.266 | 0.09 | 0.266 | Lipoxygenase inhibitor | 0.215 0.126 CID_53790925 | ||
| 0.194 | 0.018 | 0.194 | MAP3K9 inhibitor | |||
| 0.207 | 0.032 | 0.207 | Insulin secretagoues | 0.192 0.04 CID_53790925 | ||
| 0.225 | 0.051 | 0.225 | Insulin sensitizer | 0.167 0.11 CID_53790925 | ||
| 0.18 | 0.007 | 0.18 | Ca2+-transporting ATPase inhibitor | 0.18 0.007 CID_53790925 | ||
| 0.203 | 0.031 | 0.205 | Arachidonic acid antagonist | 0.205 0.028 CID_53790925 | CID_53790925 | |
| 0.203 | 0.031 | 0.203 | Hemostatic | 0.155 0.062 CID_53790925 | ||
| 0.268 | 0.098 | 0.272 | Caspase 3 stimulant | 0.272 0.095 CID_53790925 | CID_53790925 | |
| 0.233 | 0.065 | 0.233 | Psychostimulant | 0.216 0.072 CID_53790925 | ||
| 0.201 | 0.034 | 0.201 | Hexokinase inhibitor | 0.155 0.073 CID_53790925 | ||
| 0.187 | 0.02 | 0.187 | Adenylate cyclase stimulant | 0.187 0.021 CID_53790925 | ||
| 0.181 | 0.015 | 0.181 | TRPA1 agonist | |||
| 0.183 | 0.019 | 0.183 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.142 0.029 CID_53790925 | ||
| 0.248 | 0.085 | 0.248 | Transcription factor STAT3 inhibitor | |||
| 0.176 | 0.015 | 0.176 | Creatine kinase inhibitor | 0.163 0.019 CID_53790925 | ||
| 0.178 | 0.018 | 0.178 | GABA C receptor antagonist | 0.105 0.071 CID_53790925 | ||
| 0.18 | 0.021 | 0.202 | UDP-glucose 4-epimerase inhibitor | 0.202 0.018 CID_53790925 | CID_53790925 | |
| 0.195 | 0.039 | 0.195 | Activin receptor-like kinase 2 inhibitor | |||
| 0.246 | 0.09 | 0.246 | Transcription factor STAT inhibitor | |||
| 0.176 | 0.021 | 0.176 | Pregnane X receptor agonist | 0.141 0.072 CID_53790925 | ||
| 0.177 | 0.023 | 0.177 | 5 Hydroxytryptamine 3A agonist | |||
| 0.172 | 0.017 | 0.172 | Estrogen antagonist | 0.141 0.028 CID_53790925 | ||
| 0.205 | 0.053 | 0.205 | Mcl-1 antagonist | 0.123 0.121 CID_53790925 | ||
| 0.178 | 0.026 | 0.178 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.168 | 0.016 | 0.168 | Triose-phosphate isomerase inhibitor | 0.163 0.017 CID_53790925 | ||
| 0.2 | 0.048 | 0.2 | Cytidine deaminase inhibitor | |||
| 0.195 | 0.043 | 0.219 | Melanin inhibitor | 0.219 0.035 CID_53790925 | CID_53790925 | |
| 0.228 | 0.079 | 0.228 | Neuropeptide Y2 antagonist | |||
| 0.164 | 0.015 | 0.164 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.121 0.029 CID_53790925 | ||
| 0.167 | 0.02 | 0.167 | Nav1.5 sodium channel blocker | |||
| 0.19 | 0.043 | 0.19 | Cyclin-dependent kinase 8 inhibitor | 0.126 0.108 CID_53790925 | ||
| 0.159 | 0.014 | 0.159 | Estrogen receptor beta antagonist | 0.127 0.025 CID_53790925 | ||
| 0.164 | 0.019 | 0.164 | Uric acid excretion stimulant | |||
| 0.153 | 0.008 | 0.153 | Sphingosine 1-phosphate receptor 4 agonist | 0.072 0.042 CID_53790925 | ||
| 0.176 | 0.031 | 0.176 | Cathepsin H inhibitor | 0.132 0.062 CID_53790925 | ||
| 0.165 | 0.022 | 0.165 | Heat shock protein 70 antagonist | 0.143 0.063 CID_53790925 | ||
| 0.188 | 0.046 | 0.215 | Interferon gamma antagonist | 0.215 0.036 CID_53790925 | CID_53790925 | |
| 0.19 | 0.048 | 0.19 | Amylase inhibitor | 0.18 0.051 CID_53790925 | ||
| 0.154 | 0.013 | 0.154 | Histamine N-methyltransferase inhibitor | 0.099 0.046 CID_53790925 | ||
| 0.185 | 0.045 | 0.185 | Neurotensin receptor agonist | |||
| 0.308 | 0.167 | 0.6 | Apoptosis agonist | 0.6 0.049 CID_53790925 | CID_53790925 | |
| 0.151 | 0.011 | 0.151 | Lanosterol 14 alpha demethylase inhibitor | 0.118 0.032 CID_53790925 | ||
| 0.151 | 0.012 | 0.151 | Phenylalanine 4-hydroxylase inhibitor | 0.096 0.027 CID_53790925 | ||
| 0.272 | 0.133 | 0.272 | Calpain 2 inhibitor | |||
| 0.262 | 0.123 | 0.262 | Vasodilator, coronary | 0.241 0.143 CID_53790925 | ||
| 0.18 | 0.042 | 0.18 | Nav1.2 sodium channel blocker | |||
| 0.156 | 0.019 | 0.156 | GABA C receptor rho-1 antagonist | |||
| 0.155 | 0.02 | 0.155 | Prolactin inhibitor | 0.088 0.069 CID_53790925 | ||
| 0.164 | 0.03 | 0.164 | MAP kinase 13 inhibitor | |||
| 0.139 | 0.005 | 0.139 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.09 0.013 CID_53790925 | ||
| 0.137 | 0.005 | 0.137 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.136 | 0.003 | 0.136 | Microsomal triglyceride transfer protein inhibitor | |||
| 0.139 | 0.007 | 0.139 | Granulocyte macrophage colony stimulating factor agonist | 0.084 0.065 CID_53790925 | ||
| 0.17 | 0.038 | 0.17 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | |||
| 0.169 | 0.038 | 0.169 | Abl kinase inhibitor | |||
| 0.134 | 0.004 | 0.134 | Complement C5a chemotactic receptor antagonist | |||
| 0.133 | 0.005 | 0.133 | 5 Hydroxytryptamine 7 agonist | 0.055 0.042 CID_53790925 | ||
| 0.132 | 0.004 | 0.132 | Exportin-1 inhibitor | 0.084 0.02 CID_53790925 | ||
| 0.253 | 0.125 | 0.312 | Sodium/bile acid cotransporter inhibitor | 0.312 0.069 CID_53790925 | CID_53790925 | |
| 0.15 | 0.023 | 0.15 | Androgen antagonist | 0.097 0.048 CID_53790925 | ||
| 0.145 | 0.019 | 0.145 | Glutamate receptor agonist | |||
| 0.148 | 0.022 | 0.148 | DOPA decarboxylase inhibitor | 0.102 0.071 CID_53790925 | ||
| 0.138 | 0.013 | 0.138 | Bromodomain-containing protein 2 inhibitor | |||
| 0.128 | 0.004 | 0.128 | Retinoid X alpha receptor agonist | 0.05 0.014 CID_53790925 | ||
| 0.144 | 0.02 | 0.144 | Acetylcholine release stimulant | |||
| 0.143 | 0.019 | 0.152 | NADH dehydrogenase inhibitor | 0.152 0.017 CID_53790925 | CID_53790925 | |
| 0.166 | 0.044 | 0.166 | Sodium channel (voltage-gated) blocker | |||
| 0.133 | 0.012 | 0.133 | Glycine receptor antagonist | 0.126 0.015 CID_53790925 | ||
| 0.141 | 0.02 | 0.141 | ABCA1 expression enhancer | |||
| 0.197 | 0.077 | 0.197 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.127 | 0.007 | 0.127 | Progesterone antagonist | 0.119 0.008 CID_53790925 | ||
| 0.15 | 0.031 | 0.15 | DNA repair enzyme inhibitor | 0.13 0.055 CID_53790925 | ||
| 0.123 | 0.004 | 0.123 | Corticotropin releasing factor 2 receptor antagonist | 0.058 0.052 CID_53790925 | ||
| 0.146 | 0.028 | 0.153 | Adenylate kinase inhibitor | 0.153 0.025 CID_53790925 | CID_53790925 | |
| 0.133 | 0.015 | 0.133 | Glutamate release inhibitor | 0.085 0.075 CID_53790925 | ||
| 0.152 | 0.035 | 0.152 | GABA receptor agonist | |||
| 0.136 | 0.018 | 0.136 | Phosphodiesterase 3A inhibitor | |||
| 0.129 | 0.012 | 0.129 | Biliverdin reductase inhibitor | 0.117 0.014 CID_53790925 | ||
| 0.158 | 0.041 | 0.229 | Cholesterol synthesis inhibitor | 0.229 0.021 CID_53790925 | CID_53790925 | |
| 0.193 | 0.077 | 0.193 | I kappa B kinase epsilon inhibitor | |||
| 0.131 | 0.015 | 0.131 | Estrogen receptor alpha antagonist | 0.125 0.017 CID_53790925 | ||
| 0.171 | 0.055 | 0.179 | Protein kinase stimulant | 0.179 0.051 CID_53790925 | CID_53790925 | |
| 0.119 | 0.005 | 0.119 | Glutamate (mGluR7) antagonist | 0.083 0.024 CID_53790925 | ||
| 0.214 | 0.1 | 0.214 | Calpain inhibitor | |||
| 0.154 | 0.041 | 0.154 | DNA intercalator | 0.112 0.063 CID_53790925 | ||
| 0.19 | 0.078 | 0.19 | Focal adhesion kinase 2 inhibitor | |||
| 0.127 | 0.014 | 0.127 | mTOR complex 2 inhibitor | 0.089 0.048 CID_53790925 | ||
| 0.218 | 0.107 | 0.218 | Spasmolytic | 0.188 0.13 CID_53790925 | ||
| 0.168 | 0.058 | 0.168 | Cyclooxygenase inhibitor | |||
| 0.138 | 0.027 | 0.138 | Protein kinase C delta inhibitor | |||
| 0.114 | 0.005 | 0.114 | Dihydroorotase inhibitor | |||
| 0.122 | 0.013 | 0.122 | D-Ala-D-Ala ligase inhibitor | 0.089 0.047 CID_53790925 | ||
| 0.132 | 0.023 | 0.132 | MAP kinase 14 inhibitor | |||
| 0.15 | 0.041 | 0.15 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.142 | 0.035 | 0.142 | CC chemokine 6 receptor antagonist | 0.136 0.05 CID_53790925 | ||
| 0.174 | 0.067 | 0.174 | Phospholipase C inhibitor | 0.171 0.072 CID_53790925 | ||
| 0.146 | 0.04 | 0.233 | Microtubule formation inhibitor | 0.233 0.013 CID_53790925 | CID_53790925 | |
| 0.156 | 0.05 | 0.156 | Cyclooxygenase 2 inhibitor | |||
| 0.134 | 0.028 | 0.15 | Anabolic | 0.15 0.018 CID_53790925 | CID_53790925 | |
| 0.11 | 0.004 | 0.11 | Retinoid X receptor agonist | 0.051 0.018 CID_53790925 | ||
| 0.142 | 0.037 | 0.142 | Xanthine oxidase inhibitor | |||
| 0.132 | 0.028 | 0.132 | Electrolyte absorption antagonist | |||
| 0.135 | 0.032 | 0.135 | Sphingomyelinase inhibitor | |||
| 0.133 | 0.03 | 0.133 | Interleukin 2 antagonist | 0.13 0.033 CID_53790925 | ||
| 0.11 | 0.007 | 0.11 | Glutamate (mGluR6) antagonist | 0.093 0.014 CID_53790925 | ||
| 0.144 | 0.042 | 0.144 | Alpha 2b adrenoreceptor antagonist | |||
| 0.108 | 0.006 | 0.108 | TRPM8 blocker | |||
| 0.11 | 0.01 | 0.11 | Phospholipase D inhibitor | 0.068 0.058 CID_53790925 | ||
| 0.115 | 0.014 | 0.115 | Glycine receptor agonist | 0.113 0.015 CID_53790925 | ||
| 0.145 | 0.044 | 0.145 | Beta amyloid protein antagonist | |||
| 0.108 | 0.008 | 0.108 | 5 Hydroxytryptamine 2 agonist | |||
| 0.156 | 0.056 | 0.156 | Alkaline phosphatase inhibitor | |||
| 0.108 | 0.009 | 0.108 | Fatty acid synthase inhibitor | 0.058 0.038 CID_53790925 | ||
| 0.12 | 0.022 | 0.12 | 5 Hydroxytryptamine 7 antagonist | |||
| 0.151 | 0.053 | 0.151 | NADPH oxidase inhibitor | |||
| 0.152 | 0.055 | 0.152 | Cyclooxygenase 1 inhibitor | |||
| 0.103 | 0.007 | 0.103 | Glutamate (mGluR group II) agonist | |||
| 0.126 | 0.03 | 0.126 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.102 | 0.006 | 0.102 | 5 Hydroxytryptamine 1B agonist | |||
| 0.105 | 0.01 | 0.105 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.083 0.032 CID_53790925 | ||
| 0.11 | 0.016 | 0.116 | Alcohol oxidase inhibitor | 0.116 0.015 CID_53790925 | CID_53790925 | |
| 0.115 | 0.021 | 0.115 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.109 | 0.015 | 0.109 | Elastase 1 inhibitor | |||
| 0.135 | 0.041 | 0.135 | Protein kinase C gamma inhibitor | |||
| 0.161 | 0.068 | 0.161 | Diuretic | |||
| 0.118 | 0.025 | 0.118 | GABA A receptor agonist | |||
| 0.233 | 0.14 | 0.233 | Antithrombotic | 0.212 0.163 CID_53790925 | ||
| 0.099 | 0.006 | 0.099 | Glutamate (mGluR2) agonist | |||
| 0.112 | 0.02 | 0.112 | Glutamate (mGluR) agonist | |||
| 0.123 | 0.032 | 0.123 | Catalase inhibitor | |||
| 0.1 | 0.009 | 0.1 | Sphingosine 1-phosphate receptor 5 agonist | 0.051 0.044 CID_53790925 | ||
| 0.149 | 0.058 | 0.16 | Tubulin antagonist | 0.16 0.054 CID_53790925 | CID_53790925 | |
| 0.098 | 0.007 | 0.098 | Transcription factor RelA inhibitor | 0.072 0.027 CID_53790925 | ||
| 0.103 | 0.012 | 0.103 | Aryl hydrocarbon receptor antagonist | |||
| 0.148 | 0.058 | 0.148 | Toll-Like receptor antagonist | |||
| 0.151 | 0.061 | 0.151 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.106 | 0.017 | 0.106 | Potassium channel Kv1.5 blocker | |||
| 0.132 | 0.042 | 0.132 | Transcription factor STAT6 inhibitor | |||
| 0.105 | 0.016 | 0.105 | CC chemokine 5 receptor agonist | |||
| 0.154 | 0.065 | 0.154 | Thiol protease inhibitor | |||
| 0.152 | 0.063 | 0.152 | Cell wall synthesis inhibitor | 0.15 0.066 CID_53790925 | ||
| 0.14 | 0.052 | 0.143 | Adenylate cyclase inhibitor | 0.143 0.05 CID_53790925 | CID_53790925 | |
| 0.15 | 0.062 | 0.15 | MAP kinase kinase 4 inhibitor | |||
| 0.15 | 0.063 | 0.15 | Toll-Like receptor 9 antagonist | |||
| 0.093 | 0.007 | 0.093 | DNA helicase inhibitor | 0.053 0.041 CID_53790925 | ||
| 0.098 | 0.012 | 0.098 | Estrogen receptor beta agonist | 0.043 0.021 CID_53790925 | ||
| 0.094 | 0.009 | 0.094 | Nicotinic alpha3beta2 receptor antagonist | 0.049 0.047 CID_53790925 | ||
| 0.101 | 0.015 | 0.101 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.115 | 0.03 | 0.115 | Ornithine decarboxylase inhibitor | 0.104 0.04 CID_53790925 | ||
| 0.138 | 0.053 | 0.266 | Alkylator | 0.266 0.015 CID_53790925 | CID_53790925 | |
| 0.131 | 0.047 | 0.131 | MAO A inhibitor | |||
| 0.129 | 0.046 | 0.129 | 5-Lipoxygenase inhibitor | |||
| 0.088 | 0.004 | 0.088 | Alpha 1d adrenoreceptor agonist | |||
| 0.098 | 0.015 | 0.098 | Alpha 2 adrenoreceptor agonist | |||
| 0.15 | 0.067 | 0.15 | MAP kinase 3 inhibitor | |||
| 0.103 | 0.021 | 0.103 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.09 | 0.008 | 0.09 | Calcium channel P-type blocker | 0.064 0.042 CID_53790925 | ||
| 0.186 | 0.105 | 0.186 | Hypolipemic | 0.149 0.137 CID_53790925 | ||
| 0.094 | 0.013 | 0.094 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.117 | 0.037 | 0.117 | Calcium antagonist | |||
| 0.105 | 0.025 | 0.105 | Prostaglandin-E synthase inhibitor | |||
| 0.109 | 0.03 | 0.109 | Cathepsin G inhibitor | |||
| 0.096 | 0.016 | 0.101 | Androgen agonist | 0.101 0.014 CID_53790925 | CID_53790925 | |
| 0.11 | 0.031 | 0.11 | Bile acid receptor antagonist | 0.098 0.054 CID_53790925 | ||
| 0.12 | 0.041 | 0.12 | Potassium channel (Ca-activated) activator | |||
| 0.094 | 0.015 | 0.106 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.106 0.013 CID_53790925 | CID_53790925 | |
| 0.092 | 0.014 | 0.092 | Heat shock protein 90 beta antagonist | 0.085 0.017 CID_53790925 | ||
| 0.095 | 0.016 | 0.095 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.132 | 0.053 | 0.132 | Interleukin 1b antagonist | |||
| 0.085 | 0.006 | 0.085 | Adenylate cyclase 1 inhibitor | 0.071 0.012 CID_53790925 | ||
| 0.142 | 0.064 | 0.142 | Sodium channel blocker | |||
| 0.135 | 0.057 | 0.135 | Vanilloid 1 agonist | 0.113 0.107 CID_53790925 | ||
| 0.136 | 0.058 | 0.136 | Nav1.3 sodium channel blocker | |||
| 0.08 | 0.003 | 0.08 | Imidazoline I1 receptor antagonist | |||
| 0.101 | 0.024 | 0.101 | Estrogen-related receptor beta agonist | 0.093 0.036 CID_53790925 | ||
| 0.094 | 0.017 | 0.094 | 5 Hydroxytryptamine 2A agonist | |||
| 0.12 | 0.044 | 0.12 | Carbonic anhydrase III inhibitor | |||
| 0.126 | 0.049 | 0.126 | Aminopeptidase B inhibitor | |||
| 0.096 | 0.02 | 0.096 | Vanilloid 4 agonist | 0.077 0.046 CID_53790925 | ||
| 0.121 | 0.045 | 0.121 | Beta glucuronidase inhibitor | 0.103 0.065 CID_53790925 | ||
| 0.111 | 0.035 | 0.111 | Phosphodiesterase 6D inhibitor | 0.094 0.064 CID_53790925 | ||
| 0.097 | 0.022 | 0.097 | Aromatase inhibitor | 0.065 0.038 CID_53790925 | ||
| 0.102 | 0.027 | 0.102 | Interferon agonist | 0.084 0.046 CID_53790925 | ||
| 0.084 | 0.01 | 0.084 | Bcl-xL inhibitor | |||
| 0.079 | 0.005 | 0.079 | GABA uptake inhibitor | 0.039 0.027 CID_53790925 | ||
| 0.127 | 0.053 | 0.127 | Interleukin 8 antagonist | |||
| 0.092 | 0.019 | 0.092 | NMDA 2C receptor antagonist | |||
| 0.093 | 0.019 | 0.093 | TRPA1 antagonist | |||
| 0.092 | 0.018 | 0.092 | Carbonic anhydrase VB inhibitor | |||
| 0.092 | 0.019 | 0.092 | Orexin receptor 1 antagonist | |||
| 0.1 | 0.027 | 0.1 | GABA aminotransferase inhibitor | 0.07 0.062 CID_53790925 | ||
| 0.114 | 0.042 | 0.114 | Nitric-oxide synthase inhibitor | |||
| 0.117 | 0.045 | 0.152 | Gastric antisecretory | 0.152 0.026 CID_53790925 | CID_53790925 | |
| 0.145 | 0.073 | 0.145 | Neuropeptide Y1 antagonist | |||
| 0.083 | 0.011 | 0.083 | Estrogen receptor alpha agonist | 0.067 0.014 CID_53790925 | ||
| 0.084 | 0.012 | 0.084 | Aconitate hydratase inhibitor | 0.053 0.034 CID_53790925 | ||
| 0.158 | 0.086 | 0.158 | Antipruritic | |||
| 0.079 | 0.008 | 0.079 | Urate transporter 1 inhibitor | |||
| 0.134 | 0.063 | 0.134 | Antibacterial (Helicobacter pylori) | 0.115 0.089 CID_53790925 | ||
| 0.249 | 0.178 | 0.457 | Antibacterial | 0.457 0.054 CID_53790925 | CID_53790925 | |
| 0.075 | 0.004 | 0.075 | Free fatty acid receptor 1 antagonist | 0.045 0.012 CID_53790925 | ||
| 0.082 | 0.011 | 0.082 | Farnesyltransferase inhibitor | |||
| 0.098 | 0.028 | 0.098 | Carbonic anhydrase V inhibitor | |||
| 0.137 | 0.066 | 0.137 | MAO inhibitor | |||
| 0.078 | 0.008 | 0.078 | Thymidylate synthase inhibitor | 0.052 0.025 CID_53790925 | ||
| 0.074 | 0.004 | 0.074 | Guanylate cyclase inhibitor | 0.068 0.005 CID_53790925 | ||
| 0.077 | 0.007 | 0.077 | Immunoglobulin Fc receptor antagonist | |||
| 0.119 | 0.05 | 0.119 | Alpha 2c adrenoreceptor antagonist | |||
| 0.088 | 0.021 | 0.088 | Cannabinoid CB1 receptor antagonist | |||
| 0.076 | 0.009 | 0.076 | Pregnane X receptor antagonist | 0.059 0.032 CID_53790925 | ||
| 0.093 | 0.027 | 0.093 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.098 | 0.032 | 0.106 | Keratolytic | 0.106 0.027 CID_53790925 | CID_53790925 | |
| 0.089 | 0.023 | 0.089 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.084 | 0.019 | 0.084 | Transcription factor AP-1 inhibitor | 0.062 0.041 CID_53790925 | ||
| 0.096 | 0.03 | 0.096 | Aminopeptidase I inhibitor | 0.077 0.045 CID_53790925 | ||
| 0.097 | 0.032 | 0.097 | Caspase 7 inhibitor | |||
| 0.075 | 0.01 | 0.075 | Sphingosine 1-phosphate receptor agonist | |||
| 0.09 | 0.025 | 0.09 | Beta tubulin antagonist | 0.071 0.034 CID_53790925 | ||
| 0.07 | 0.005 | 0.07 | Nerve growth factor antagonist | |||
| 0.098 | 0.033 | 0.113 | Phosphofructokinase-1 inhibitor | 0.113 0.027 CID_53790925 | CID_53790925 | |
| 0.093 | 0.028 | 0.093 | Carbonic anhydrase VA inhibitor | |||
| 0.198 | 0.134 | 0.198 | Streptokinase A inhibitor | |||
| 0.085 | 0.023 | 0.085 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.069 | 0.007 | 0.069 | Retinoic acid alpha receptor agonist | |||
| 0.074 | 0.013 | 0.074 | Aldosterone antagonist | |||
| 0.1 | 0.039 | 0.1 | Carbonic anhydrase VI inhibitor | |||
| 0.155 | 0.094 | 0.155 | Tumour necrosis factor antagonist | |||
| 0.069 | 0.008 | 0.069 | Sirtuin 2 inhibitor | |||
| 0.069 | 0.008 | 0.069 | Geranyltranstransferase inhibitor | 0.048 0.025 CID_53790925 | ||
| 0.084 | 0.023 | 0.084 | Orexin receptor antagonist | |||
| 0.065 | 0.005 | 0.065 | Retinoid X receptor antagonist | 0.039 0.025 CID_53790925 | ||
| 0.106 | 0.046 | 0.106 | Potassium channel (Voltage-sensitive) activator | |||
| 0.093 | 0.034 | 0.093 | Glutamate dehydrogenase inhibitor | 0.093 0.035 CID_53790925 | ||
| 0.068 | 0.009 | 0.068 | Glutamate (mGluR group II) antagonist | |||
| 0.063 | 0.004 | 0.063 | Free fatty acid receptor 1 agonist | 0.021 0.009 CID_53790925 | ||
| 0.091 | 0.033 | 0.091 | Cannabinoid receptor antagonist | |||
| 0.082 | 0.024 | 0.082 | Purinergic P2X1 antagonist | 0.078 0.026 CID_53790925 | ||
| 0.096 | 0.037 | 0.096 | Macrophage migration inhibitory factor inhibitor | |||
| 0.087 | 0.029 | 0.087 | MAP kinase kinase 7 inhibitor | 0.08 0.046 CID_53790925 | ||
| 0.112 | 0.054 | 0.112 | Urease inhibitor | |||
| 0.072 | 0.014 | 0.072 | Mineralocorticoid receptor antagonist | |||
| 0.155 | 0.097 | 0.155 | CDC-like kinase 4 inhibitor | |||
| 0.079 | 0.021 | 0.079 | MDM2 inhibitor | 0.072 0.032 CID_53790925 | ||
| 0.076 | 0.018 | 0.095 | Glucosylceramidase inhibitor | 0.095 0.009 CID_53790925 | CID_53790925 | |
| 0.124 | 0.067 | 0.124 | Histone deacetylase class III inhibitor | |||
| 0.062 | 0.005 | 0.062 | Angiotensin AT1 receptor antagonist | |||
| 0.086 | 0.029 | 0.086 | Nav1.7 sodium channel blocker | |||
| 0.171 | 0.115 | 0.171 | Potassium channel blocker | |||
| 0.071 | 0.015 | 0.071 | CD45 antagonist | |||
| 0.086 | 0.029 | 0.086 | Secretase beta inhibitor | |||
| 0.096 | 0.04 | 0.096 | Inducible nitric-oxide synthase inhibitor | |||
| 0.106 | 0.049 | 0.106 | Glutamate (mGluR7) agonist | |||
| 0.112 | 0.056 | 0.112 | AMP-activated protein kinase stimulant | 0.093 0.081 CID_53790925 | ||
| 0.079 | 0.023 | 0.079 | Estrogen agonist | 0.056 0.032 CID_53790925 | ||
| 0.072 | 0.016 | 0.072 | Topoisomerase II beta inhibitor | 0.048 0.037 CID_53790925 | ||
| 0.077 | 0.021 | 0.112 | Alpha tubulin antagonist | 0.112 0.014 CID_53790925 | CID_53790925 | |
| 0.115 | 0.059 | 0.13 | Mucolytic | 0.13 0.046 CID_53790925 | CID_53790925 | |
| 0.066 | 0.01 | 0.066 | Glutamate (mGluR group III) antagonist | |||
| 0.14 | 0.085 | 0.14 | Phospholipase A2 inhibitor | |||
| 0.105 | 0.05 | 0.105 | MAP kinase kinase 1 inhibitor | |||
| 0.078 | 0.023 | 0.078 | Acyl-CoA dehydrogenase inhibitor | 0.074 0.025 CID_53790925 | ||
| 0.07 | 0.015 | 0.07 | Estradiol 17 beta-dehydrogenase inhibitor | 0.039 0.032 CID_53790925 | ||
| 0.069 | 0.014 | 0.069 | Squalene epoxidase inhibitor | 0.045 0.044 CID_53790925 | ||
| 0.076 | 0.022 | 0.076 | Cyclin D1 inhibitor | |||
| 0.082 | 0.028 | 0.09 | Carbamoyl phosphate synthetase inhibitor | 0.09 0.024 CID_53790925 | CID_53790925 | |
| 0.085 | 0.03 | 0.085 | Acetylcholine M5 receptor agonist | |||
| 0.09 | 0.036 | 0.09 | Glutamate decarboxylase inhibitor | |||
| 0.095 | 0.041 | 0.095 | Myeloperoxidase inhibitor | |||
| 0.074 | 0.022 | 0.074 | Cannabinoid CB2 receptor antagonist | |||
| 0.082 | 0.03 | 0.082 | Potassium channel (Tandem pore domain) blocker | |||
| 0.07 | 0.018 | 0.07 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.057 | 0.005 | 0.057 | Cholesterol ester transfer protein antagonist | 0.048 0.008 CID_53790925 | ||
| 0.056 | 0.004 | 0.056 | Retinoid X alpha receptor antagonist | 0.034 0.023 CID_53790925 | ||
| 0.119 | 0.068 | 0.119 | Anesthetic local | |||
| 0.063 | 0.011 | 0.063 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.065 | 0.014 | 0.065 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.066 | 0.015 | 0.084 | Glucose-6-phosphate isomerase inhibitor | 0.084 0.008 CID_53790925 | CID_53790925 | |
| 0.06 | 0.009 | 0.06 | 5 Hydroxytryptamine 2B agonist | |||
| 0.069 | 0.018 | 0.069 | Potassium channel (Inward rectifier) blocker | |||
| 0.077 | 0.027 | 0.077 | Interferon inducer | 0.065 0.043 CID_53790925 | ||
| 0.246 | 0.196 | 0.246 | MAP kinase kinase 6 inhibitor | |||
| 0.055 | 0.005 | 0.055 | Angiotensin II receptor antagonist | |||
| 0.059 | 0.01 | 0.059 | Acid-sensing ion channel blocker | |||
| 0.09 | 0.041 | 0.093 | Na+ K+ transporting ATPase inhibitor | 0.093 0.038 CID_53790925 | CID_53790925 | |
| 0.055 | 0.006 | 0.055 | Melatonin receptor 1A agonist | |||
| 0.078 | 0.03 | 0.078 | Potassium channel (ATP-sensitive) blocker | |||
| 0.093 | 0.044 | 0.093 | Glutathione S-transferase inhibitor | |||
| 0.059 | 0.012 | 0.059 | Dopamine D5 agonist | 0.036 0.034 CID_53790925 | ||
| 0.054 | 0.007 | 0.054 | Glutamate (mGluR2) antagonist | |||
| 0.065 | 0.018 | 0.065 | Potassium channel Kv1.3 blocker | |||
| 0.059 | 0.013 | 0.059 | Liver X receptor alpha agonist | |||
| 0.058 | 0.012 | 0.058 | Dihydrofolate reductase inhibitor | |||
| 0.083 | 0.037 | 0.083 | GABA B receptor agonist | |||
| 0.115 | 0.069 | 0.115 | Proteasome inhibitor | |||
| 0.07 | 0.024 | 0.07 | Toll-Like receptor 8 antagonist | |||
| 0.078 | 0.033 | 0.078 | Protein kinase C beta inhibitor | |||
| 0.066 | 0.021 | 0.066 | Dihydroorotate oxidase inhibitor | |||
| 0.052 | 0.006 | 0.052 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.074 | 0.028 | 0.074 | Argininosuccinate synthase inhibitor | 0.074 0.028 CID_53790925 | ||
| 0.054 | 0.008 | 0.054 | Calcium release-activated channel blocker | |||
| 0.056 | 0.011 | 0.056 | Diamine oxidase inhibitor | |||
| 0.096 | 0.051 | 0.096 | Alpha 2 adrenoreceptor antagonist | |||
| 0.081 | 0.037 | 0.081 | Dopamine agonist | |||
| 0.121 | 0.077 | 0.121 | Cyclooxygenase 3 inhibitor | |||
| 0.112 | 0.067 | 0.112 | Monophenol monooxygenase inhibitor | 0.09 0.084 CID_53790925 | ||
| 0.057 | 0.013 | 0.057 | Glucocorticoid antagonist | |||
| 0.068 | 0.024 | 0.068 | Sphingosine kinase 2 inhibitor | 0.055 0.038 CID_53790925 | ||
| 0.053 | 0.01 | 0.053 | MAP3K5 inhibitor | |||
| 0.051 | 0.007 | 0.051 | ATP citrate lysase inhibitor | 0.04 0.013 CID_53790925 | ||
| 0.051 | 0.008 | 0.051 | Liver X receptor beta antagonist | |||
| 0.107 | 0.064 | 0.107 | Falcipain 3 inhibitor | |||
| 0.061 | 0.019 | 0.061 | Potassium channel (Inward rectifier) activator | |||
| 0.058 | 0.015 | 0.058 | Benzodiazepine antagonist | |||
| 0.055 | 0.013 | 0.055 | Histamine H1 receptor agonist | |||
| 0.071 | 0.029 | 0.071 | Phosphodiesterase 1C inhibitor | |||
| 0.111 | 0.07 | 0.111 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.074 | 0.032 | 0.074 | 5 Hydroxytryptamine 3 agonist | |||
| 0.096 | 0.055 | 0.096 | Protein kinase C zeta inhibitor | |||
| 0.057 | 0.016 | 0.057 | Cytokine production stimulant | |||
| 0.049 | 0.009 | 0.049 | Vanilloid 3 antagonist | 0.036 0.034 CID_53790925 | ||
| 0.047 | 0.007 | 0.047 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.104 | 0.064 | 0.153 | Expectorant | 0.153 0.034 CID_53790925 | CID_53790925 | |
| 0.052 | 0.012 | 0.052 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.058 | 0.018 | 0.058 | Potassium channel (ATP-sensitive) activator | |||
| 0.043 | 0.003 | 0.043 | Complement factor 1s inhibitor | |||
| 0.166 | 0.127 | 0.166 | Antiamyloidogenic | |||
| 0.069 | 0.029 | 0.069 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.099 | 0.06 | 0.099 | MAO B inhibitor | |||
| 0.201 | 0.162 | 0.201 | Thyroid hormone antagonist | |||
| 0.058 | 0.019 | 0.058 | Glutamate (mGluR5) agonist | |||
| 0.044 | 0.006 | 0.044 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.018 0.015 CID_53790925 | ||
| 0.198 | 0.16 | 0.198 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.043 | 0.005 | 0.043 | Dopamine D1 agonist | 0.027 0.011 CID_53790925 | ||
| 0.054 | 0.016 | 0.054 | GABA B receptor antagonist | |||
| 0.041 | 0.004 | 0.041 | Alpha 2a adrenoreceptor agonist | |||
| 0.044 | 0.008 | 0.044 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.023 0.015 CID_53790925 | ||
| 0.05 | 0.014 | 0.05 | Heme oxygenase inhibitor | |||
| 0.079 | 0.043 | 0.079 | Phosphodiesterase VI inhibitor | |||
| 0.06 | 0.024 | 0.06 | Heparanase inhibitor | 0.056 0.031 CID_53790925 | ||
| 0.074 | 0.038 | 0.074 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.069 | 0.033 | 0.069 | I kappa B kinase 2 inhibitor | |||
| 0.085 | 0.05 | 0.085 | Transforming growth factor beta 3 antagonist | |||
| 0.1 | 0.065 | 0.1 | Hedgehog signaling inhibitor | |||
| 0.088 | 0.054 | 0.088 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.058 | 0.024 | 0.058 | Glutamate (mGluR group I) agonist | |||
| 0.085 | 0.051 | 0.085 | Acetylcholine nicotinic agonist | |||
| 0.193 | 0.16 | 0.193 | Thyroid hormone beta antagonist | |||
| 0.114 | 0.081 | 0.114 | Glutamate receptor antagonist | |||
| 0.073 | 0.039 | 0.073 | Bcl2 antagonist | |||
| 0.092 | 0.058 | 0.092 | Potassium channel activator | |||
| 0.079 | 0.046 | 0.079 | Histone deacetylase SIRT2 inhibitor | |||
| 0.035 | 0.003 | 0.035 | Progesterone receptor A antagonist | 0.01 0.006 CID_53790925 | ||
| 0.038 | 0.005 | 0.038 | Apolipoprotein B inhibitor | |||
| 0.066 | 0.034 | 0.066 | Xanthine dehydrogenase inhibitor | |||
| 0.176 | 0.144 | 0.176 | Cardiotonic | |||
| 0.118 | 0.086 | 0.118 | Protein-tyrosine kinase Lyn inhibitor | |||
| 0.038 | 0.006 | 0.038 | Nicotinic acid receptor 2 antagonist | |||
| 0.047 | 0.015 | 0.047 | Orexin receptor 2 antagonist | |||
| 0.155 | 0.123 | 0.155 | Anticonvulsant | |||
| 0.08 | 0.048 | 0.08 | Alpha 2a adrenoreceptor antagonist | |||
| 0.048 | 0.017 | 0.048 | Kainate receptor agonist | 0.041 0.028 CID_53790925 | ||
| 0.035 | 0.004 | 0.035 | Retinoid X beta receptor antagonist | 0.021 0.013 CID_53790925 | ||
| 0.047 | 0.016 | 0.047 | Somatostatin 4 agonist | |||
| 0.053 | 0.023 | 0.053 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.039 | 0.008 | 0.039 | Calcium-sensing receptor agonist | |||
| 0.034 | 0.003 | 0.034 | Imidazoline I2 receptor antagonist | |||
| 0.037 | 0.007 | 0.037 | Geranylgeranyltransferase inhibitor | |||
| 0.056 | 0.027 | 0.056 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.035 | 0.005 | 0.035 | Apolipoprotein B-100 inhibitor | |||
| 0.173 | 0.143 | 0.248 | Hypoglycemic | 0.248 0.078 CID_53790925 | CID_53790925 | |
| 0.079 | 0.05 | 0.079 | Glutamate (mGluR) antagonist | |||
| 0.037 | 0.007 | 0.037 | Retinoic acid receptor agonist | |||
| 0.037 | 0.008 | 0.037 | Retinoid X gamma receptor agonist | |||
| 0.033 | 0.005 | 0.033 | Retinoic acid beta receptor agonist | |||
| 0.072 | 0.044 | 0.072 | Alpha adrenoreceptor agonist | |||
| 0.035 | 0.007 | 0.035 | Retinoid X beta receptor agonist | |||
| 0.035 | 0.007 | 0.035 | Hedgehog signaling activator | 0.031 0.012 CID_53790925 | ||
| 0.06 | 0.032 | 0.06 | Nicotinic alpha7 receptor agonist | |||
| 0.044 | 0.016 | 0.044 | Delayed rectifier potassium channel blocker | 0.037 0.027 CID_53790925 | ||
| 0.034 | 0.007 | 0.034 | Glutamate (mGluR1a) agonist | |||
| 0.044 | 0.017 | 0.044 | CF transmembrane conductance regulator antagonist | |||
| 0.083 | 0.056 | 0.083 | I kappa B kinase inhibitor | |||
| 0.063 | 0.036 | 0.063 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | |||
| 0.049 | 0.022 | 0.049 | Glutamate (mGluR4) antagonist | |||
| 0.068 | 0.042 | 0.068 | Dopamine D1 antagonist | |||
| 0.062 | 0.035 | 0.062 | Sphingosine kinase inhibitor | 0.056 0.047 CID_53790925 | ||
| 0.058 | 0.031 | 0.058 | NMDA 2A receptor antagonist | |||
| 0.035 | 0.009 | 0.035 | Myristoyl transferase inhibitor | |||
| 0.066 | 0.04 | 0.066 | NMDA receptor glycine site agonist | |||
| 0.108 | 0.082 | 0.108 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.032 | 0.007 | 0.032 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.076 | 0.051 | 0.076 | Acetylcholine M4 receptor antagonist | |||
| 0.078 | 0.053 | 0.078 | Somatostatin 1 agonist | |||
| 0.085 | 0.06 | 0.085 | Acetylcholine agonist | |||
| 0.03 | 0.005 | 0.03 | Alpha 2c adrenoreceptor agonist | |||
| 0.062 | 0.037 | 0.062 | Potassium channel (Ca-activated) blocker | |||
| 0.061 | 0.036 | 0.061 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.149 | 0.124 | 0.149 | Death-associated protein kinase 3 inhibitor | |||
| 0.041 | 0.016 | 0.041 | Ceramide glucosyltransferase inhibitor | 0.036 0.023 CID_53790925 | ||
| 0.06 | 0.036 | 0.06 | Protein kinase C theta inhibitor | |||
| 0.14 | 0.116 | 0.14 | DNA methyltransferase I inhibitor | |||
| 0.062 | 0.038 | 0.062 | Carbonic anhydrase stimulant | |||
| 0.032 | 0.008 | 0.032 | Vanilloid 2 agonist | 0.028 0.012 CID_53790925 | ||
| 0.049 | 0.026 | 0.049 | Purinergic P2X4 antagonist | |||
| 0.044 | 0.021 | 0.044 | 5-Alpha-reductase inhibitor | |||
| 0.056 | 0.033 | 0.056 | Lysine-specific demethylase 1A inhibitor | |||
| 0.042 | 0.019 | 0.042 | Glutamate (mGluR8) agonist | |||
| 0.029 | 0.007 | 0.029 | Retinoic acid alpha receptor antagonist | |||
| 0.058 | 0.036 | 0.058 | Kallikrein 1 inhibitor | |||
| 0.072 | 0.049 | 0.072 | Histidine decarboxylase inhibitor | |||
| 0.074 | 0.052 | 0.074 | Rho-associated kinase I inhibitor | |||
| 0.049 | 0.027 | 0.049 | Purinergic P2Y antagonist | 0.046 0.03 CID_53790925 | ||
| 0.039 | 0.017 | 0.039 | Melatonin 2 agonist | |||
| 0.039 | 0.016 | 0.039 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.051 | 0.029 | 0.051 | Cholesterol esterase inhibitor | |||
| 0.03 | 0.008 | 0.03 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.06 | 0.038 | 0.06 | Dopamine uptake inhibitor | |||
| 0.06 | 0.038 | 0.06 | Botulinum neurotoxin type A inhibitor | |||
| 0.07 | 0.048 | 0.07 | I kappa B kinase 1 inhibitor | |||
| 0.032 | 0.01 | 0.032 | Retinoid X gamma receptor antagonist | |||
| 0.042 | 0.021 | 0.042 | Farnesoid X receptor agonist | 0.038 0.025 CID_53790925 | ||
| 0.038 | 0.017 | 0.038 | Melatonin 1 agonist | |||
| 0.083 | 0.062 | 0.14 | Antineoplastic alkaloid | 0.14 0.031 CID_53790925 | CID_53790925 | |
| 0.059 | 0.039 | 0.059 | Ryanodine receptor antagonist | |||
| 0.032 | 0.012 | 0.065 | Sodium/glucose cotransporter 2 inhibitor | 0.065 0.005 CID_53790925 | CID_53790925 | |
| 0.026 | 0.006 | 0.026 | Progesterone receptor B antagonist | |||
| 0.025 | 0.005 | 0.025 | Follicle-stimulating hormone antagonist | |||
| 0.074 | 0.054 | 0.074 | Carbonic anhydrase XIII inhibitor | |||
| 0.112 | 0.092 | 0.112 | Lck kinase inhibitor | |||
| 0.08 | 0.061 | 0.08 | Thioredoxin reductase inhibitor | |||
| 0.116 | 0.096 | 0.116 | Histone deacetylase SIRT1 inhibitor | |||
| 0.033 | 0.013 | 0.033 | 5 Hydroxytryptamine 6 agonist | |||
| 0.035 | 0.016 | 0.035 | Glucagon receptor antagonist | |||
| 0.04 | 0.021 | 0.04 | Glutamate (mGluR3) antagonist | |||
| 0.026 | 0.007 | 0.026 | Retinoic acid receptor antagonist | |||
| 0.033 | 0.014 | 0.033 | Thiazolidinedione | |||
| 0.06 | 0.041 | 0.06 | Prostaglandin EP2 antagonist | |||
| 0.042 | 0.024 | 0.042 | NMDA receptor subunit 3A antagonist | |||
| 0.054 | 0.036 | 0.054 | Leukotriene B4 antagonist | 0.052 0.04 CID_53790925 | ||
| 0.034 | 0.017 | 0.034 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.036 | 0.019 | 0.036 | Liver X receptor beta agonist | |||
| 0.034 | 0.016 | 0.034 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.033 | 0.016 | 0.033 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.045 | 0.029 | 0.045 | NMDA receptor subunit 3B antagonist | |||
| 0.043 | 0.026 | 0.043 | Thymidine kinase inhibitor | 0.041 0.028 CID_53790925 | ||
| 0.026 | 0.009 | 0.026 | Retinoic acid gamma receptor agonist | |||
| 0.036 | 0.02 | 0.036 | Adenosine uptake inhibitor | |||
| 0.051 | 0.035 | 0.051 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.055 | 0.038 | 0.055 | Epithelial sodium channel blocker | |||
| 0.051 | 0.035 | 0.051 | Factor IXa inhibitor | |||
| 0.029 | 0.013 | 0.029 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.028 0.015 CID_53790925 | ||
| 0.034 | 0.018 | 0.034 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.032 | 0.016 | 0.032 | Liver X receptor alpha antagonist | |||
| 0.038 | 0.023 | 0.038 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.02 | 0.004 | 0.02 | Human herpes virus 5 capsid protein P40 inhibitor | |||
| 0.037 | 0.021 | 0.038 | Fumarate hydratase inhibitor | 0.038 0.02 CID_53790925 | CID_53790925 | |
| 0.053 | 0.038 | 0.053 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.023 | 0.008 | 0.023 | G-protein-coupled receptor 120 agonist | |||
| 0.056 | 0.041 | 0.056 | Leukotriene C antagonist | |||
| 0.028 | 0.013 | 0.047 | Sodium/glucose cotransporter inhibitor | 0.047 0.005 CID_53790925 | CID_53790925 | |
| 0.045 | 0.031 | 0.045 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.023 | 0.009 | 0.023 | Progesterone agonist | |||
| 0.021 | 0.007 | 0.021 | NMDA receptor phencyclidine site antagonist | |||
| 0.039 | 0.025 | 0.039 | Potassium channel Kv1.1 blocker | |||
| 0.07 | 0.056 | 0.07 | CDC25A inhibitor | |||
| 0.028 | 0.014 | 0.028 | Thymidine phosphorylase inhibitor | |||
| 0.03 | 0.016 | 0.03 | Estrogen-related receptor gamma antagonist | |||
| 0.102 | 0.088 | 0.102 | Caspase 3 inhibitor | |||
| 0.025 | 0.011 | 0.025 | Geranylgeranyltransferase I inhibitor | |||
| 0.029 | 0.015 | 0.029 | Glucosylceramidase stimulant | |||
| 0.073 | 0.06 | 0.073 | Fibroblast growth factor 3 antagonist | |||
| 0.022 | 0.008 | 0.022 | Alpha 2b adrenoreceptor agonist | |||
| 0.067 | 0.054 | 0.067 | NMDA 2 receptor antagonist | |||
| 0.027 | 0.014 | 0.027 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.037 | 0.024 | 0.037 | Nicotinic acid receptor agonist | |||
| 0.017 | 0.005 | 0.017 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.032 | 0.02 | 0.032 | Liver X receptor antagonist | |||
| 0.023 | 0.01 | 0.023 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.021 0.014 CID_53790925 | ||
| 0.017 | 0.005 | 0.017 | Egl nine homolog 3 inhibitor | |||
| 0.03 | 0.018 | 0.03 | Purinergic P2Y15 antagonist | 0.03 0.017 CID_53790925 | ||
| 0.092 | 0.08 | 0.092 | Mediator release inhibitor | |||
| 0.019 | 0.007 | 0.019 | Angiotensin AT1B receptor antagonist | |||
| 0.046 | 0.034 | 0.049 | Adenosine deaminase inhibitor | 0.049 0.032 CID_53790925 | CID_53790925 | |
| 0.044 | 0.032 | 0.044 | 5 Hydroxytryptamine 2C agonist | |||
| 0.067 | 0.055 | 0.067 | Benzodiazepine agonist | |||
| 0.124 | 0.112 | 0.124 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.139 | 0.128 | 0.139 | DNA methylase inhibitor | |||
| 0.052 | 0.041 | 0.052 | Acetylcholine muscarinic agonist | |||
| 0.026 | 0.015 | 0.026 | Acid ceramidase inhibitor | |||
| 0.02 | 0.009 | 0.02 | Nicotinic acid receptor 1 antagonist | |||
| 0.023 | 0.012 | 0.023 | Angiotensin AT1A receptor antagonist | |||
| 0.041 | 0.03 | 0.041 | Sphingosine kinase 1 inhibitor | |||
| 0.068 | 0.057 | 0.068 | MAP kinase 11 inhibitor | |||
| 0.042 | 0.031 | 0.042 | Histamine H2 receptor agonist | |||
| 0.04 | 0.029 | 0.04 | Phenylethanolamine N methyltransferase inhibitor | |||
| 0.153 | 0.142 | 0.153 | MAP kinase kinase 5 inhibitor | |||
| 0.04 | 0.029 | 0.04 | Glutamate (mGluR1a) antagonist | |||
| 0.022 | 0.011 | 0.022 | Toll-Like receptor 8 agonist | |||
| 0.02 | 0.009 | 0.02 | CXC chemokine 5 receptor antagonist | |||
| 0.057 | 0.047 | 0.057 | Phosphodiesterase 1B inhibitor | |||
| 0.043 | 0.032 | 0.043 | Phosphodiesterase 3B inhibitor | |||
| 0.046 | 0.035 | 0.046 | AMPA receptor antagonist | |||
| 0.098 | 0.089 | 0.098 | Activin receptor-like kinase 4 inhibitor | |||
| 0.034 | 0.025 | 0.034 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.082 | 0.073 | 0.082 | Pim-3 kinase inhibitor | |||
| 0.089 | 0.079 | 0.089 | Insulin receptor antagonist | |||
| 0.015 | 0.006 | 0.015 | Cyclin D2 inhibitor | |||
| 0.054 | 0.045 | 0.054 | Glutamate (mGluR1) antagonist | |||
| 0.036 | 0.027 | 0.036 | Integrin alpha2 antagonist | |||
| 0.047 | 0.037 | 0.047 | Histamine H4 receptor antagonist | |||
| 0.056 | 0.047 | 0.056 | Cyclin A1 inhibitor | |||
| 0.032 | 0.023 | 0.032 | Melatonin agonist | |||
| 0.051 | 0.042 | 0.059 | Alpha-mannosidase inhibitor | 0.059 0.028 CID_53790925 | CID_53790925 | |
| 0.063 | 0.055 | 0.063 | Protein kinase C alpha inhibitor | |||
| 0.027 | 0.019 | 0.027 | NMDA 2D receptor antagonist | |||
| 0.047 | 0.038 | 0.047 | Dopamine beta hydroxylase inhibitor | |||
| 0.048 | 0.04 | 0.048 | Factor III inhibitor | |||
| 0.061 | 0.053 | 0.061 | Beta 3 adrenoreceptor antagonist | |||
| 0.053 | 0.045 | 0.053 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.058 | 0.05 | 0.058 | NMDA receptor agonist | |||
| 0.027 | 0.02 | 0.027 | Uridine phosphorylase inhibitor | 0.024 0.023 CID_53790925 | ||
| 0.065 | 0.058 | 0.065 | Telomerase inhibitor | |||
| 0.111 | 0.104 | 0.111 | Interleukin 1 antagonist | |||
| 0.121 | 0.114 | 0.121 | Sigma receptor agonist | |||
| 0.03 | 0.023 | 0.03 | Potassium channel small-conductance Ca-activated activator | |||
| 0.019 | 0.013 | 0.023 | Antibiotic Anthracycline-like | 0.023 0.007 CID_53790925 | CID_53790925 | |
| 0.039 | 0.033 | 0.039 | Acetylcholine M1 receptor agonist | |||
| 0.033 | 0.027 | 0.033 | Kainate receptor 2 antagonist | |||
| 0.156 | 0.15 | 0.216 | Immunostimulant | 0.216 0.111 CID_53790925 | CID_53790925 | |
| 0.051 | 0.045 | 0.051 | Thromboxane synthase inhibitor | |||
| 0.025 | 0.019 | 0.025 | Complement factor 1r inhibitor | |||
| 0.026 | 0.021 | 0.026 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | |||
| 0.041 | 0.036 | 0.041 | AICAR transformylase inhibitor | |||
| 0.025 | 0.02 | 0.025 | Integrin alpha2beta1 antagonist | |||
| 0.037 | 0.032 | 0.037 | AMPA 4 receptor antagonist | |||
| 0.036 | 0.03 | 0.036 | DNA gyrase subunit B inhibitor | |||
| 0.017 | 0.012 | 0.019 | Telomerase stimulant | 0.019 0.009 CID_53790925 | CID_53790925 | |
| 0.009 | 0.004 | 0.009 | DNA topoisomerase III inhibitor | |||
| 0.032 | 0.027 | 0.032 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.05 | 0.045 | 0.05 | Nicotinic neuronal receptor agonist | |||
| 0.024 | 0.019 | 0.024 | Prostaglandin H2 antagonist | |||
| 0.059 | 0.054 | 0.059 | Histone deacetylase SIRT3 inhibitor | |||
| 0.014 | 0.009 | 0.014 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.097 | 0.092 | 0.097 | c-Src kinase inhibitor | |||
| 0.01 | 0.005 | 0.01 | Corticotropin releasing factor antagonist | |||
| 0.075 | 0.071 | 0.075 | Bcr-Abl kinase inhibitor | |||
| 0.031 | 0.027 | 0.031 | Glutamate (mGluR3) agonist | |||
| 0.053 | 0.049 | 0.053 | Cannabinoid CB1 receptor agonist | |||
| 0.007 | 0.004 | 0.007 | CC chemokine 6 receptor agonist | |||
| 0.02 | 0.017 | 0.02 | Histone-lysine N-methyltransferase EZH2 inhibitor | |||
| 0.115 | 0.112 | 0.115 | Src kinase inhibitor | |||
| 0.08 | 0.077 | 0.173 | ATPase (Vacuolar H+) inhibitor | 0.173 0.004 CID_53790925 | CID_53790925 | |
| 0.03 | 0.027 | 0.03 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.099 | 0.096 | 0.099 | MAP kinase kinase inhibitor | |||
| 0.011 | 0.009 | 0.011 | Retinoic acid receptor gamma antagonist | |||
| 0.012 | 0.009 | 0.012 | Retinoic acid beta receptor antagonist | |||
| 0.056 | 0.053 | 0.056 | Phosphodiesterase 1A inhibitor | |||
| 0.014 | 0.012 | 0.014 | Egl nine homolog 1 inhibitor | |||
| 0.027 | 0.025 | 0.027 | Acetylcholine M4 receptor agonist | |||
| 0.006 | 0.005 | 0.006 | Integrin alpha5beta6 antagonist | |||
| 0.023 | 0.022 | 0.023 | Prostaglandin EP4 antagonist | |||
| 0.038 | 0.037 | 0.038 | Leukocyte elastase inhibitor | |||
| 0.019 | 0.019 | 0.022 | Prostaglandin EP2 agonist | 0.022 0.016 CID_53790925 | CID_53790925 | |
| 0.258 | 0.258 | 0.424 | Antiinflammatory | 0.424 0.125 CID_53790925 | CID_53790925 | |
| 0.03 | 0.034 | 0.032 | HMG CoA reductase inhibitor | 0.032 0.028 CID_53790925 | CID_53790925 | |
| 0.054 | 0.061 | 0.057 | Leukotriene antagonist | 0.057 0.055 CID_53790925 | CID_53790925 | |
| 0.012 | 0.02 | 0.016 | Thromboxane A2 agonist | 0.016 0.009 CID_53790925 | CID_53790925 | |
| 0.089 | 0.097 | 0.266 | Topoisomerase II inhibitor | 0.266 0.022 CID_53790925 | CID_53790925 | |
| 0.037 | 0.046 | 0.046 | Mannosidase inhibitor | 0.046 0.03 CID_53790925 | CID_53790925 | |
| 0.016 | 0.029 | 0.02 | Leukotriene B4 receptor 2 antagonist | 0.02 0.019 CID_53790925 | CID_53790925 | |
| 0.078 | 0.091 | 0.132 | Topoisomerase I inhibitor | 0.132 0.049 CID_53790925 | CID_53790925 | |
| 0.204 | 0.218 | 0.227 | Alpha-glucosidase inhibitor | 0.227 0.202 CID_53790925 | CID_53790925 | |
| 0.15 | 0.165 | 0.321 | Antioxidant | 0.321 0.054 CID_53790925 | CID_53790925 | |
| 0.1 | 0.117 | 0.177 | Lipid peroxidase inhibitor | 0.177 0.052 CID_53790925 | CID_53790925 | |
| 0.058 | 0.077 | 0.094 | Topoisomerase II alpha inhibitor | 0.094 0.044 CID_53790925 | CID_53790925 | |
| 0.048 | 0.068 | 0.092 | HIV-1 integrase (3'-Processing) inhibitor | 0.092 0.029 CID_53790925 | CID_53790925 | |
| 0.136 | 0.166 | 0.183 | Free radical scavenger | 0.183 0.112 CID_53790925 | CID_53790925 | |
| 0.027 | 0.06 | 0.043 | Phosphorylase inhibitor | 0.043 0.034 CID_53790925 | CID_53790925 | |
| 0.112 | 0.166 | 0.135 | Interleukin 6 antagonist | 0.135 0.114 CID_53790925 | CID_53790925 | |
| 0.031 | 0.096 | 0.193 | HIV-1 integrase (Strand Transfer) inhibitor | 0.193 0.01 CID_53790925 | CID_53790925 | |
| 0.101 | 0.175 | 0.229 | Nitric oxide antagonist | 0.229 0.058 CID_53790925 | CID_53790925 | |
| 0.109 | 0.186 | 0.143 | P-glycoprotein inhibitor | 0.143 0.127 CID_53790925 | CID_53790925 | |
| 0.029 | 0.129 | 0.291 | Antineoplastic antibiotic | 0.291 0.01 CID_53790925 | CID_53790925 | |
| 0.187 | 0.295 | 0.33 | Cyclophilin D inhibitor | 0.33 0.138 CID_53790925 | CID_53790925 | |
| 0.005 | 0.149 | 0.025 | RNA-directed RNA polymerase stimulant | 0.025 0.024 CID_53790925 | CID_53790925 | |
| 0.018 | 0.18 | 0.033 | Tubulin agonist | 0.033 0.026 CID_53790925 | CID_53790925 | |
| 0.034 | 0.206 | 0.064 | HIV-1 integrase inhibitor | 0.064 0.06 CID_53790925 | CID_53790925 | |
| 0.073 | 0.268 | 0.102 | Sphingosine 1-phosphate receptor 2 agonist | 0.102 0.096 CID_53790925 | CID_53790925 | |
| 0.088 | 0.291 | 0.164 | Lipocortins synthesis antagonist | 0.164 0.087 CID_53790925 | CID_53790925 | |
| 0.072 | 0.276 | 0.193 | Hepatoprotectant | 0.193 0.07 CID_53790925 | CID_53790925 | |
| 0.064 | 0.29 | 0.293 | Antimitotic | 0.293 0.045 CID_53790925 | CID_53790925 | |
| 0.015 | 0.245 | 0.047 | Microtubule stabilization | 0.047 0.032 CID_53790925 | CID_53790925 | |
| 0.03 | 0.399 | 0.056 | Lipocortins synthesis agonist | 0.056 0.044 CID_53790925 | CID_53790925 | |
| 0.01 | 0.519 | 0.054 | Protein 50S ribosomal subunit inhibitor | 0.054 0.036 CID_53790925 | CID_53790925 | |
| 0.071 | 0.657 | 0.202 | Interleukin 2 agonist | 0.202 0.186 CID_53790925 | CID_53790925 | |
| 0.058 | 0.831 | 0.261 | Peptidyltransferase inhibitor | 0.261 0.043 CID_53790925 | CID_53790925 | |
| 0.003 | 0.918 | 0.015 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.015 0.009 CID_53790925 | CID_53790925 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |